Table 1.
Demographic and clinical data on the Covid-19 patients tested.
| Patients Data | Group A (Whole-Proteome Screening) |
Group B (1st Microarray Screening) |
Group C (2nd Microarray Screening) |
Group D (Test Validation) |
Group E (Longitudinal Samples) |
|---|---|---|---|---|---|
| No. patients | 7 | 12 | 28 | 50 | 5 |
| Mean age, IQR | 86 (79–95) | 78 (62–91) | 80 (72–86) | 81 (71–87) | 67 (64–72) |
| Females | 71% | 58% | 75% | 66% | 0% |
| Mild/moderate COVID-19 | 100% | 92% | 96% | 86% | 0% |
| Severe COVID-19 | 0% | 8% | 4% | 14% | 100% |
| Days since symptom onset, IQR | 28 (27–30) | 30 (25–35) | 38 (28–119) | 98 (28–120) | Time series (range 30–150 days) |